Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 154 health care companies ranked by P/S ratio, at 3426, ahead of Dianthus Therapeutics (2391) and CG Oncology (1793). Figures as of 19 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- First
- Roivant Sciences3426
- Median
- 4.3
- Combined market value
- NOK 87.46T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3426 | NOK 274.5B | NOK 378.88 | 0.85% up | 91% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2391 | NOK 47.2B | NOK 838.37 | 2.92% up | 108% up | ||
| 3 | CG OncologyCGON · Health Care | 1793 | NOK 70.3B | NOK 786.67 | 1.37% up | 97% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | 1117 | NOK 38B | NOK 391.97 | 0.55% up | 18% down | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | 263 | NOK 99.9B | NOK 1,170.49 | 0.38% down | 87% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | 180 | NOK 80.5B | NOK 1,233.98 | 0.04% up | 51% up | ||
| 7 | CytokineticsCYTK · Health Care | 81.8 | NOK 69.9B | NOK 501.49 | 0.74% up | 19% down | ||
| 8 | ImmunityBioIBRX · Health Care | 62.6 | NOK 68.8B | NOK 64.70 | 0.45% down | 232% up | ||
| 9 | InsmedINSM · Health Care | 43.8 | NOK 257.5B | NOK 1,173.94 | 1.02% up | 40% down | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | 43.2 | NOK 79.6B | NOK 1,147.84 | 0.59% down | 18% up | ||
| 11 | ModernaMRNA · Health Care | 40.8 | NOK 769.7B | NOK 1,902.26 | 0.35% down | 780% up | ||
| 12 | GRAILGRAL · Health Care | 32.8 | NOK 46.8B | NOK 1,041.92 | 5.21% up | 19% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | 30.8 | NOK 149.9B | NOK 769.30 | 1.67% up | 21% up | ||
| 14 | WatersWAT · Health Care | 28.9 | NOK 885.9B | NOK 4,507.85 | 0.29% down | 23% up | ||
| 15 | GlaukosGKOS · Health Care | 27.4 | NOK 134.9B | NOK 2,279.49 | 0.82% up | 145% up | ||
| 16 | Krystal BiotechKRYS · Health Care | 24.0 | NOK 90.6B | NOK 3,058.92 | 0.00% up | 54% up | ||
| 17 | HeartflowHTFL · Health Care | 23.5 | NOK 40.1B | NOK 456.09 | 2.46% up | 66% up | ||
| 18 | Ascendis PharmaASND · Health Care | 22.2 | NOK 171.8B | NOK 2,618.98 | 0.12% down | 29% up | ||
| 19 | Ligand PharmaceuticalsLGND · Health Care | 22.2 | NOK 57.6B | NOK 2,880.49 | 0.59% down | 50% up | ||
| 20 | Twist BioscienceTWST · Health Care | 21.5 | NOK 78.7B | NOK 1,154.29 | 2.28% up | 346% up | ||
| 21 | Guardant HealthGH · Health Care | 21.1 | NOK 201.2B | NOK 1,487.00 | 5.62% up | 45% up | ||
| 22 | Eli LillyLLY · Health Care | 18.7 | NOK 11.81T | NOK 13,256.71 | 1.13% down | 33% up | ||
| 23 | NateraNTRA · Health Care | 18.6 | NOK 416.3B | NOK 2,871.18 | 2.25% up | 28% up | ||
| 24 | Adaptive BiotechnologiesADPT · Health Care | 17.1 | NOK 45.8B | NOK 283.21 | 2.59% up | 74% up | ||
| 25 | Royalty PharmaRPRX · Health Care | 16.6 | NOK 382.1B | NOK 664.54 | 0.23% down | 79% up | ||
| 26 | TG TherapeuticsTGTX · Health Care | 16.2 | NOK 97B | NOK 641.55 | 0.03% up | 117% up | ||
| 27 | RepligenRGEN · Health Care | 15.3 | NOK 109.3B | NOK 1,710.05 | 2.10% up | 12% up | ||
| 28 | Intuitive SurgicalISRG · Health Care | 14.5 | NOK 1.42T | NOK 4,091.53 | 0.20% up | 24% down | ||
| 29 | BillionToOneBLLN · Health Care | 14.5 | NOK 42.9B | NOK 897.83 | 1.11% up | 4% down | ||
| 30 | argenxARGX · Health Care | 14.2 | NOK 571.8B | NOK 9,092.14 | 0.42% down | 2% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 12.7 | NOK 529.7B | NOK 6,723.61 | 0.76% down | 1% up | ||
| 32 | 10x GenomicsTXG · Health Care | 12.2 | NOK 76.1B | NOK 578.60 | 4.52% up | 247% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | 11.6 | NOK 58.6B | NOK 898.31 | 0.13% up | 34% up | ||
| 34 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | NOK 1.31T | NOK 5,176.08 | 0.53% down | 27% up | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | 11.1 | NOK 68.8B | NOK 1,307.94 | 0.63% up | 6% down | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | NOK 72.4B | NOK 921.06 | 0.10% down | 129% up | ||
| 37 | Edwards LifesciencesEW · Health Care | 10.0 | NOK 585.9B | NOK 1,018.88 | 0.15% down | 25% up | ||
| 38 | Travere TherapeuticsTVTX · Health Care | 9.9 | NOK 47B | NOK 489.51 | 0.45% up | 45% up | ||
| 39 | Corcept TherapeuticsCORT · Health Care | 9.7 | NOK 71.9B | NOK 657.32 | 0.04% down | 10% down | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | 9.7 | NOK 90.5B | NOK 3,894.62 | 0.86% up | 27% down | ||
| 41 | Bio-TechneTECH · Health Care | 9.4 | NOK 110.8B | NOK 705.30 | 0.05% down | 24% up | ||
| 42 | West Pharmaceutical ServicesWST · Health Care | 9.1 | NOK 270.5B | NOK 3,883.03 | 0.92% down | 57% up | ||
| 43 | PenumbraPEN · Health Care | 9.0 | NOK 122.6B | NOK 3,109.99 | 0.04% up | 15% up | ||
| 44 | BeOne MedicinesONC · Health Care | 8.6 | NOK 446.8B | NOK 3,911.89 | 0.08% down | 16% up | ||
| 45 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | NOK 335.1B | NOK 16,847.97 | 0.04% down | 24% up | ||
| 46 | GenmabGMAB · Health Care | 8.6 | NOK 308.7B | NOK 500.71 | 1.28% up | 70% up | ||
| 47 | AbbVieABBV · Health Care | 8.2 | NOK 4.84T | NOK 2,738.44 | 1.27% down | 25% up | ||
| 48 | United TherapeuticsUTHR · Health Care | 7.7 | NOK 236.4B | NOK 5,551.28 | 0.87% down | 22% up | ||
| 49 | Halozyme TherapeuticsHALO · Health Care | 7.6 | NOK 102.3B | NOK 897.34 | 3.43% down | 39% up | ||
| 50 | IlluminaILMN · Health Care | 7.4 | NOK 313.6B | NOK 2,074.28 | 1.83% up | 76% up | ||
| 51 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | NOK 59B | NOK 417.34 | 0.20% down | 13% up | ||
| 52 | Agilent TechnologiesA · Health Care | 7.2 | NOK 486.4B | NOK 1,725.13 | 0.33% up | 22% up | ||
| 53 | Medpace HoldingsMEDP · Health Care | 7.2 | NOK 176B | NOK 6,293.52 | 0.30% up | 10% up | ||
| 54 | Caris Life SciencesCAI · Health Care | 7.1 | NOK 55.9B | NOK 194.97 | 3.08% up | 19% down | ||
| 55 | Gilead SciencesGILD · Health Care | 7.1 | NOK 2.01T | NOK 1,624.55 | 0.89% down | 35% up | ||
| 56 | ExelixisEXEL · Health Care | 7.0 | NOK 158.6B | NOK 649.85 | 1.90% down | 63% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 6.8 | NOK 6.25T | NOK 2,596.58 | 1.84% down | 34% up | ||
| 58 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | NOK 938.1B | NOK 9,068.09 | 1.13% down | 28% up | ||
| 59 | DexComDXCM · Health Care | 6.6 | NOK 297.7B | NOK 798.11 | 0.29% down | 41% up | ||
| 60 | DanaherDHR · Health Care | 6.6 | NOK 1.56T | NOK 2,222.45 | 0.29% up | 3% up | ||
| 61 | BioNTechBNTX · Health Care | 6.5 | NOK 199.6B | NOK 804.90 | 0.34% down | 14% down | ||
| 62 | AmgenAMGN · Health Care | 6.4 | NOK 2.3T | NOK 4,244.21 | 1.43% down | 32% up | ||
| 63 | HealthEquityHQY · Health Care | 6.1 | NOK 77.9B | NOK 941.96 | 0.21% down | 3% down | ||
| 64 | RevvityRVTY · Health Care | 6.0 | NOK 166.8B | NOK 1,494.03 | 0.99% up | 62% up | ||
| 65 | ResMedRMD · Health Care | 6.0 | NOK 327.5B | NOK 2,328.37 | 1.06% down | 1% down | ||
| 66 | Thermo Fisher ScientificTMO · Health Care | 5.8 | NOK 2.5T | NOK 6,758.92 | 0.57% up | 21% up | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.7 | NOK 157.8B | NOK 1,558.88 | 1.32% down | 17% up | ||
| 68 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | NOK 194.5B | NOK 1,451.89 | 0.19% up | 66% down | ||
| 69 | AlkermesALKS · Health Care | 5.3 | NOK 76B | NOK 452.26 | 0.48% down | 66% up | ||
| 70 | NovartisNVS · Health Care | 5.3 | NOK 2.78T | NOK 1,471.48 | 2.29% down | 25% up | ||
| 71 | Merck & CoMRK · Health Care | 5.1 | NOK 3.23T | NOK 1,312.21 | 1.79% down | 45% up | ||
| 72 | QiagenQGEN · Health Care | 4.9 | NOK 99.5B | NOK 481.89 | 0.24% up | 9% up | ||
| 73 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | NOK 44B | NOK 264.42 | 0.47% down | 63% down | ||
| 74 | StrykerSYK · Health Care | 4.7 | NOK 1.16T | NOK 3,038.75 | 1.52% down | 12% down | ||
| 75 | AstraZenecaAZN · Health Care | 4.7 | NOK 2.65T | NOK 1,709.91 | 1.39% down | 1% up | ||
| 76 | IncyteINCY · Health Care | 4.6 | NOK 231.7B | NOK 1,136.74 | 0.52% down | 16% up | ||
| 77 | Lantheus HoldingsLNTH · Health Care | 4.3 | NOK 64.8B | NOK 990.46 | 0.11% up | 90% up | ||
| 78 | STERISSTE · Health Care | 4.2 | NOK 242.4B | NOK 2,495.75 | 0.89% down | 1% up | ||
| 79 | HaemoneticsHAE · Health Care | 4.2 | NOK 54.1B | NOK 1,188.73 | 0.29% down | 64% up | ||
| 80 | Abbott LaboratoriesABT · Health Care | 4.1 | NOK 1.77T | NOK 1,019.80 | 0.62% up | 16% down | ||
| 81 | Charles River Laboratories InternationalCRL · Health Care | 4.0 | NOK 156.1B | NOK 3,257.29 | 0.81% up | 106% up | ||
| 82 | Bio-Rad LaboratoriesBIO · Health Care | 3.9 | NOK 99B | NOK 3,679.67 | 2.48% up | 22% up | ||
| 83 | Novo NordiskNVO · Health Care | 3.8 | NOK 1.68T | NOK 381.69 | 0.25% down | 17% down | ||
| 84 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | NOK 116.6B | NOK 601.83 | 1.00% up | 17% up | ||
| 85 | LivaNovaLIVN · Health Care | 3.7 | NOK 50B | NOK 907.23 | 1.07% down | 77% up | ||
| 86 | BiogenBIIB · Health Care | 3.7 | NOK 355.4B | NOK 2,404.13 | 1.42% down | 49% up | ||
| 87 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | NOK 152.6B | NOK 2,377.84 | 1.06% down | 41% up | ||
| 88 | MSA SafetyMSA · Health Care | 3.7 | NOK 66.8B | NOK 1,733.38 | 0.68% up | 16% up | ||
| 89 | LifeStance Health GroupLFST · Health Care | 3.6 | NOK 50.2B | NOK 132.16 | 1.05% down | 123% up | ||
| 90 | InsuletPODD · Health Care | 3.6 | NOK 95.2B | NOK 1,372.76 | 1.10% up | 55% down | ||
| 91 | ZoetisZTS · Health Care | 3.6 | NOK 328.1B | NOK 807.42 | 2.72% down | 26% down | ||
| 92 | MedtronicMDT · Health Care | 3.5 | NOK 1.25T | NOK 978.14 | 0.15% up | 1% up | ||
| 93 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | NOK 120.7B | NOK 144.72 | 0.40% down | 8% up | ||
| 94 | AlconALC · Health Care | 3.5 | NOK 348.2B | NOK 724.73 | 0.68% down | 0% up | ||
| 95 | Merit Medical SystemsMMSI · Health Care | 3.3 | NOK 49.3B | NOK 822.07 | 1.37% down | 1% up | ||
| 96 | TeleflexTFX · Health Care | 3.3 | NOK 63.5B | NOK 1,601.27 | 0.55% down | 58% up | ||
| 97 | Boston ScientificBSX · Health Care | 3.2 | NOK 613.9B | NOK 423.55 | 0.01% up | 55% down | ||
| 98 | Globus MedicalGMED · Health Care | 3.1 | NOK 89.8B | NOK 677.78 | 0.93% down | 14% down | ||
| 99 | Legend BiotechLEGN · Health Care | 3.0 | NOK 30.3B | NOK 156.17 | 0.92% down | 41% down | ||
| 100 | PTC TherapeuticsPTCT · Health Care | 2.9 | NOK 48.5B | NOK 580.06 | 0.71% down | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6999 NOK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/S ratio?
Roivant Sciences (3426), Dianthus Therapeutics (2391) and CG Oncology (1793) are the top three of the 154 health care companies ranked by P/S ratio as of 19 Nov 2026, 14:43 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of NOK 87.46T as of 19 Nov 2026, 14:43 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.